Breaking News Instant updates and real-time market news.

DOVA

Dova Pharmaceuticals

$22.55

-0.37 (-1.61%)

16:12
08/09/18
08/09
16:12
08/09/18
16:12

Dova Pharmaceuticals reports Q2 EPS (70c), consensus (63c)

For the second quarter of 2018, Dova reported net product sales from DOPTELET of $2.0 million. The Company recognizes revenue using the sell-in methodology when products are delivered to its specialty pharmacy partners. The majority of net sales recognized in the quarter were related to the initial stocking of DOPTELET at the specialty pharmacies. In addition, in March 2018, Dova entered into an exclusive distribution agreement with Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., (Fosun Pharma Industrial). Dova received a $5.0 million upfront payment from Fosun Pharma Industrial of which $2.6 million was recognized as revenue during the second quarter of 2018. There were no product sales or other revenue in the second quarter of 2017. As of June 30, 2018, Dova had $134.7 million in cash and equivalents compared to $94.8 million as of December 31, 2017.

  • 09

    Aug

DOVA Dova Pharmaceuticals
$22.55

-0.37 (-1.61%)

09/26/17
09/26/17
UPGRADE
Target $32

Outperform
Dova Pharmaceuticals upgraded to Outperform at Leerink
As previously reported, Leerink analyst Geoffrey Porges upgraded Dova Pharmaceuticals to Outperform from Market Perform after Shionogi announced results from its phase III trial investigating thrombopoietin receptor agonist lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing an invasive procedure. The analyst notes that lusutrombopag is from the same class of drugs as Dova's avatrombopag, but is less effective ex-Japan, and believes Dova's avatrombopag has advantage. Porges also raised his price target on Dova's shares to $32 from $24.
11/28/17
JEFF
11/28/17
NO CHANGE
Target $33
JEFF
Buy
Dova Pharmaceuticals price target raised to $33 from $30 at Jefferies
Jefferies analyst Eun Yang raised her price target for Dova Pharmaceuticals to $33 after avatrombopag received FDA priority review with an action date of May 21, 2018. The analyst sees a higher probability for regulatory success of 95% and potential approval three months earlier than previously thought. She keeps a Buy rating on Dova.
04/26/18
LTCO
04/26/18
INITIATION
Target $65
LTCO
Buy
Dova Pharmaceuticals initiated with a Buy at Ladenburg
Ladenburg Thalmann analyst Matthew Kaplan started Dova Pharmaceuticals with a Buy rating and $65 price target.
07/09/18
LEER
07/09/18
DOWNGRADE
LEER
Market Perform
Dova Pharmaceuticals downgraded to Market Perform from Outperform at Leerink

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
08/15/18
08/15
12:17
08/15/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
08/15/18
08/15
12:16
08/15/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$280.78

-3.02 (-1.06%)

12:11
08/15/18
08/15
12:11
08/15/18
12:11
Technical Analysis
Technical Take: SPDR S&P 500 ETF off lows at midday »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$280.78

-3.02 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$22.53

-0.635 (-2.74%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Recommendations
Vodafone analyst commentary  »

Vodafone added as a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$335.00

-12.6 (-3.62%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Recommendations
Tesla analyst commentary  »

Tesla moved to Not Rated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LB

L Brands

$31.63

-1.1 (-3.36%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Options
Bullish longer-term option play in L Brands ahead of earnings next week »

Bullish longer-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

AMP

Ameriprise

$137.45

-1.23 (-0.89%)

12:10
08/15/18
08/15
12:10
08/15/18
12:10
Hot Stocks
Ameriprise to pay $4.5M for not safeguarding client assets »

The Securities and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHN

Schnitzer Steel

$25.95

-2.3 (-8.14%)

12:09
08/15/18
08/15
12:09
08/15/18
12:09
Conference/Events
Schnitzer Steel management to meet with KeyBanc »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

TSLA

Tesla

$334.50

-13.1 (-3.77%)

, GS

Goldman Sachs

$229.91

0.38 (0.17%)

12:08
08/15/18
08/15
12:08
08/15/18
12:08
Periodicals
Breaking Periodicals news story on Tesla, Goldman Sachs »

Goldman Sachs to act as…

TSLA

Tesla

$334.50

-13.1 (-3.77%)

GS

Goldman Sachs

$229.91

0.38 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

CRC

California Resources

$28.77

-3.32 (-10.35%)

12:05
08/15/18
08/15
12:05
08/15/18
12:05
Options
California Resources call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

TSLA

Tesla

$334.80

-12.8 (-3.68%)

12:04
08/15/18
08/15
12:04
08/15/18
12:04
Periodicals
Silver Lake would like to participate in Tesla deal, DealBook says »

Silver Lake, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ATVI

Activision Blizzard

$68.98

-2.31 (-3.24%)

, SNE

Sony

$53.46

-0.83 (-1.53%)

12:02
08/15/18
08/15
12:02
08/15/18
12:02
Hot Stocks
Activision's Call of Duty World League Championship comes to Ohio this week »

Activision Blizzard…

ATVI

Activision Blizzard

$68.98

-2.31 (-3.24%)

SNE

Sony

$53.46

-0.83 (-1.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Sep

  • 13

    Sep

PFGC

Performance Food Group

$33.30

-4.3 (-11.44%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Performance Food Group falls -11.4% »

Performance Food Group is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

CANG

Cango

$8.90

-1.6 (-15.24%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Cango falls -12.0% »

Cango is down -12.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$36.24

-5.63 (-13.45%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Macy's falls -13.4% »

Macy's is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 17

    Sep

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$10.22

1.31 (14.70%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 14.6% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMG

KMG Chemicals

$77.39

10.61 (15.89%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
KMG Chemicals rises 15.7% »

KMG Chemicals is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$30.29

5.67 (23.03%)

12:00
08/15/18
08/15
12:00
08/15/18
12:00
Hot Stocks
Canopy Growth rises 22.9% »

Canopy Growth is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

12:00
08/15/18
08/15
12:00
08/15/18
12:00
General news
Short-covering on the S&P 500 ahead of 2.8k »

Short-covering on the…

M

Macy's

$36.27

-5.6 (-13.37%)

, STZ

Constellation Brands, also tag STZ.B

$202.15

-19.62 (-8.85%)

11:57
08/15/18
08/15
11:57
08/15/18
11:57
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened deep in…

M

Macy's

$36.27

-5.6 (-13.37%)

STZ

Constellation Brands, also tag STZ.B

$202.15

-19.62 (-8.85%)

CGC

Canopy Growth

$30.21

5.59 (22.71%)

KMG

KMG Chemicals

$77.30

10.52 (15.75%)

CCMP

Cabot Microelectronics

$111.65

-9.67 (-7.97%)

PETQ

PetIQ

$34.99

6.73 (23.81%)

FANG

Diamondback Energy

$120.33

-13.42 (-10.03%)

EGN

Energen

$76.24

3.09 (4.22%)

CASA

Casa Systems

$12.20

-3.425 (-21.93%)

STZ.B

Constellation Brands

$212.44

-8.54 (-3.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 15

    Aug

  • 15

    Aug

  • 21

    Aug

  • 22

    Aug

  • 11

    Sep

  • 17

    Sep

  • 25

    Oct

  • 28

    Oct

APC

Anadarko

$64.41

-2.56 (-3.82%)

11:55
08/15/18
08/15
11:55
08/15/18
11:55
Options
Anadarko put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRVS

Corvus Pharmaceuticals

$9.47

0.44 (4.87%)

11:55
08/15/18
08/15
11:55
08/15/18
11:55
Upgrade
Corvus Pharmaceuticals rating change  »

Corvus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXS

BancorpSouth

$34.20

-0.2 (-0.58%)

11:45
08/15/18
08/15
11:45
08/15/18
11:45
Conference/Events
BancorpSouth management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

BXS

BancorpSouth

$34.20

-0.2 (-0.58%)

11:45
08/15/18
08/15
11:45
08/15/18
11:45
Conference/Events
BancorpSouth management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

ALRM

Alarm.com

$50.63

0.02 (0.04%)

11:43
08/15/18
08/15
11:43
08/15/18
11:43
Conference/Events
Alarm.com management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 22

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.